2025. A preliminary study on the prognostic significance of cysteine-rich EGF ligand domain 2 protein (CRELD2) in patients with triple negative breast cancer. Biomolecules and Biomedicine. 25, 7 (May 2025), 1663–1671. DOI:https://doi.org/10.17305/bb.2024.11865.